Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Mathieu Drouin"'
Publikováno v:
AAPS Open, Vol 4, Iss 1, Pp 1-6 (2018)
Abstract Fingolimod is an oral agent approved for the treatment of relapsing forms of multiple sclerosis (MS), which has demonstrated efficacy in Phase III trials in patients with relapsing-remitting MS (RRMS). The present study was designed to asses
Externí odkaz:
https://doaj.org/article/95f3551078a8484a957739a7f06216e7
Publikováno v:
Vox Sanguinis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36b5d7f0e4b31ddaaee03fd218cc1b8b
https://doi.org/10.1111/vox.13447
https://doi.org/10.1111/vox.13447
Autor:
Antoine Lewin, Gaston De Serres, Yves Grégoire, Josée Perreault, Mathieu Drouin, Marie-Josée Fournier, Tony Tremblay, Julie Beaudoin, Amélie Boivin, Guillaume Goyette, Andrés Finzi, Renée Bazin, Marc Germain, Gilles Delage, Christian Renaud
Publikováno v:
Canadian journal of public health = Revue canadienne de sante publique. 113(3)
We previously estimated the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies following the first pandemic wave at 2.23% in Québec, Canada. Following the much bigger second wave in fall 2020 and early 2021, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cda3c45657925c6570effee5b77be28
https://pubmed.ncbi.nlm.nih.gov/35380364
https://pubmed.ncbi.nlm.nih.gov/35380364
Autor:
Renée Bazin, Gilles Delage, Tony Tremblay, Antoine Lewin, Yves Grégoire, Julie Beaudoin, Gaston De Serres, Jérémie Prévost, Mathieu Drouin, Roseline Therrien, Guillaume Beaudoin-Bussières, Marie-Josée Fournier, Gabrielle Gendron-Lepage, Andrés Finzi, Josée Perreault, Marc Germain
Publikováno v:
Canadian Journal of Public Health = Revue Canadienne de Santé Publique
A substantial proportion of individuals infected with SARS-CoV-2 do not experience noticeable symptoms typical of COVID-19. Our objectives were to evaluate the impact of the first wave of the pandemic in Québec by measuring SARS-CoV-2 antibody serop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0303d76d0a6dace27f686c15e87fd4b
https://pubmed.ncbi.nlm.nih.gov/33999398
https://pubmed.ncbi.nlm.nih.gov/33999398
Autor:
Antoine Lewin, Mathieu Drouin, Jérémie Prévost, Renée Bazin, Tony Tremblay, Marie-Josée Fournier, Andrés Finzi, Josée Perreault, Sai Priya Anand, Jonathan Richard
Publikováno v:
Transfusion
Background The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus is the cause of the ongoing coronavirus disease 2019 (COVID‐19) pandemic, infecting millions of people and causing more than two million deaths. The SARS‐CoV‐
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c8e476c351b45835eec6640462e26b0
https://pubmed.ncbi.nlm.nih.gov/33604922
https://pubmed.ncbi.nlm.nih.gov/33604922
Autor:
Antoine Lewin, Jonathan Richard, Mathieu Drouin, Josée Perreault, Jérémie Prévost, Sai Priya Anand, Marie-Josée Fournier, Renée Bazin, Tony Tremblay, Andrés Finzi
BackgroundThe SARS-CoV-2 virus is the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic, infecting millions of people and causing more than a million deaths. The SARS-CoV-2 Spike glycoproteins mediate viral entry and represent the mai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::812c288a547c7e2d648a870886a8e117
https://doi.org/10.1101/2020.10.20.346783
https://doi.org/10.1101/2020.10.20.346783
Autor:
Antoine Lewin, Jérémie Prévost, Guillaume Beaudoin-Bussières, Mathieu Drouin, Philippe Bégin, Andrés Finzi, Josée Perreault, Marie Josée Fournier, Renée Bazin, Tony Tremblay
Publikováno v:
Blood
Perreault and colleagues examined antibody titers in sequential samples from serum donors recovering from COVID-19 and demonstrated that antibody titers fall over 3-4 months. These results have important implications for convalescent serum collection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c1514b304f7f52513ce0914a34e9e5d
https://pubmed.ncbi.nlm.nih.gov/33242330
https://pubmed.ncbi.nlm.nih.gov/33242330
Autor:
Jérémie Prévost, Marie-Josée Fournier, Philippe Bégin, Renée Bazin, Mathieu Drouin, Tony Tremblay, Josée Perreault, Guillaume Beaudoin-Bussières, Andrés Finzi, Antoine Lewin
Héma-Québec, the blood supplier in the Province of Quebec, Canada, collects and tests convalescent plasma used in a clinical trial to determine the clinical efficacy of this product for the treatment of hospitalized COVID-19 patients. So far, we ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa77b9681bde1a82b67306d8bb20f6da
https://doi.org/10.1101/2020.07.16.206847
https://doi.org/10.1101/2020.07.16.206847
Autor:
Yannick Doyon, Guillaume Margaillan, Yelena Boccacci, Mathieu Drouin, Nellie Dumont, Josée Laganière
Publikováno v:
Experimental Hematology. 88:S55
In vitro-produced red blood cells (RBCs) could be used as cellular models for studying erythroid diseases or for providing reagent cells expressing specific blood group antigens. However, the non-fully mature state of cells achieved with current prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c320284c836542eb694cd1ced63d8e3
https://doi.org/10.1016/j.exphem.2020.09.074
https://doi.org/10.1016/j.exphem.2020.09.074
Publikováno v:
AAPS Open, Vol 4, Iss 1, Pp 1-6 (2018)
Fingolimod is an oral agent approved for the treatment of relapsing forms of multiple sclerosis (MS), which has demonstrated efficacy in Phase III trials in patients with relapsing-remitting MS (RRMS). The present study was designed to assess bioequi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb7e7fff48f11a7149b98cc498486a67
https://doi.org/10.1186/s41120-018-0023-3
https://doi.org/10.1186/s41120-018-0023-3